New ADHD pill under the microscope: how does food affect it?
NCT ID NCT07253441
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tested a new once-daily capsule form of the ADHD drug centanafadine in 174 healthy adults. Researchers checked whether different capsule strengths work the same, how food changes drug absorption, and if the new capsule matches the older tablet. The goal was to gather data for future marketing, not to treat ADHD directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Lenexa
Lenexa, Kansas, 66219, United States
-
ICON Salt Lake City
Millcreek, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.